The role of microRNAs in skin fibrosis

Archives of Dermatological Research

Volumn 305, Issue 9, 2013, Pages 763-776

  Babalola, Olubukola ^a,b   Mamalis, Andrew ^a,b   Lev Tov, Hadar ^a,b,c   Jagdeo, Jared ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Collagen; MicroRNA; miRNA; Skin fibrosis; Therapeutics

Indexed keywords

BIOLOGICAL MARKER; LET 7A; MICRORNA; MICRORNA 129 5P; MICRORNA 133A; MICRORNA 133B; MICRORNA 140 5P; MICRORNA 145; MICRORNA 150; MICRORNA 17 5P; MICRORNA 18; MICRORNA 196A; MICRORNA 20; MICRORNA 200; MICRORNA 203; MICRORNA 205; MICRORNA 206; MICRORNA 26A; MICRORNA 29; MICRORNA 7; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE FUNCTION; GENETIC ASSOCIATION; HUMAN; PRIORITY JOURNAL; REVIEW; RNA ANALYSIS; RNA DEGRADATION; SIGNAL TRANSDUCTION; SKIN FIBROSIS; UPREGULATION;

CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; KELOID; MICRORNAS; OLIGONUCLEOTIDES; SCLERODERMA, SYSTEMIC; SKIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84886723147     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-013-1410-1     Document Type: Review

References (80)

1. Abdullah A, Blakeney P, Hunt R, Broemeling L, Phillips L, Herndon DN, Robson MC (1994) Visible scars and self-esteem in pediatric patients with burns. J Burn Care Rehabil 15(2):164-168
2. Bader A, Lorenz K, Richter A, Scheffler K, Kern L, Ebert S, Giri S, Behrens M, Dornseifer U, Macchiarini P, Machens HG (2011) Interactive role of trauma cytokines and erythropoietin and their therapeutic potential for acute and chronic wounds. Rejuvenation Res 14(1):57-66. doi: 10.1089/rej.2010.1050
3. Banerjee J, Sen CK (2013) MicroRNAs in skin and wound healing. Methods Mol Biol 936:343-356. doi: 10.1007/978-1-62703-083-0-26
4. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297
5. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215-233. doi: 10.1016/j.cell.2009.01.002
6. Batkai S, Thum T (2012) MicroRNAs in hypertension: mechanisms and therapeutic targets. Curr Hypertens Rep 14(1):79-87. doi: 10.1007/s11906-011- 0235-6
7. Bolognia JL, Jorizzo JL, Schaffer JV (2012) Dermatology, 3rd edn. Mosby, St. Louis
8. Bowen T, Jenkins RH, Fraser DJ (2013) MicroRNAs, transforming growth factor beta-1, and tissue fibrosis. J Pathol 229(2):274-285. doi: 10.1002/path.4119
9. Brych SB, Engrav LH, Rivara FP, Ptacek JT, Lezotte DC, Esselman PC, Kowalske KJ, Gibran NS (2001) Time off work and return to work rates after burns: systematic review of the literature and a large two-center series. J Burn Care Rehabil 22(6):401-405
10. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18(10):997-1006. doi: 10.1038/cr.2008.282
11. Cheng J, Wang Y, Wang D, Wu Y (2013) Identification of collagen 1 as a post-transcriptional target of miR-29b in skin fibroblasts: therapeutic implication for scar reduction. Am J Med Sci 346(2):98-103. doi: 10.1097/MAJ.0b013e318267680d
12. Cheng J, Yu H, Deng S, Shen G (2010) MicroRNA profiling in mid- and late-gestational fetal skin: implication for scarless wound healing. Tohoku J Exp Med 221(3):203-209
13. Eming SA, Krieg T, Davidson JM (2004) Gene transfer in tissue repair: status, challenges and future directions. Expert Opin Biol Ther 4(9):1373-1386. doi: 10.1517/14712598.4.9.1373
14. Engrav LH, Heimbach DM, Reus JL, Harnar TJ, Marvin JA (1983) Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: a randomized prospective study. J Trauma 23(11):1001-1004
15. Etoh M, Jinnin M, Makino K, Yamane K, Nakayama W, Aoi J, Honda N, Kajihara I, Makino T, Fukushima S, Ihn H (2013) microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma. Arch Dermatol Res 305(1):9-15. doi: 10.1007/s00403-012-1287-4
16. Falanga V, Iwamoto S (2012) Mechanisms of wound repair, wound healing, and wound dressing. In: Fitzpatrick's dermatology in general medicine, 8th edn. McGraw-Hill, New York
17. Fasanaro P, Greco S, Ivan M, Capogrossi MC, Martelli F (2010) microRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacol Ther 125(1):92-104. doi: 10.1016/j.pharmthera.2009.10.003
18. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, Bentwich Z, Hod M, Goren Y, Chajut A (2008) Serum microRNAs are promising novel biomarkers. PLoS ONE 3(9):e3148. doi: 10.1371/journal.pone.0003148
19. Guo Y, Xiao L, Sun L, Liu F (2012) Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res (Acad Sci Bohemoslov) 61(4):337-346
20. Honda N, Jinnin M, Kajihara I, Makino T, Makino K, Masuguchi S, Fukushima S, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H (2012) TGF-beta-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts. J Immunol 188(7):3323-3331. doi: 10.4049/jimmunol.1100876
21. Honda N, Jinnin M, Kira-Etoh T, Makino K, Kajihara I, Makino T, Fukushima S, Inoue Y, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H (2013) miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin beta3. Am J Pathol 182(1):206-216. doi: 10.1016/j.ajpath.2012.09.023
22. Hu B, Phan SH (2013) Myofibroblasts. Curr Opin Rheumatol 25(1):71-77. doi: 10.1097/BOR.0b013e32835b1352
23. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, Nana-Sinkam SP, Jarjoura D, Marsh CB (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 3(11):e3694. doi: 10.1371/journal.pone.0003694
24. Igoucheva O, Alexeev V (2009) MicroRNA-dependent regulation of cKit in cutaneous melanoma. Biochem Biophys Res Commun 379(3):790-794. doi: 10.1016/j.bbrc.2008.12.152
25. Ishida M, Selaru FM (2013) miRNA-based therapeutic strategies. Curr Anesthesiol Rep 1(1):63-70. doi: 10.1007/s40139-012-0004-5
26. Jiang X, Tsitsiou E, Herrick SE, Lindsay MA (2010) MicroRNAs and the regulation of fibrosis. FEBS J 277(9):2015-2021. doi: 10.1111/j.1742-4658.2010. 07632.x
27. Kajihara I, Jinnin M, Yamane K, Makino T, Honda N, Igata T, Masuguchi S, Fukushima S, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H (2012) Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts. Am J Pathol 180(2):703-714. doi: 10.1016/j.ajpath.2011.10.030
28. Karakikes I, Chaanine AH, Kang S, Mukete BN, Jeong D, Zhang S, Hajjar RJ, Lebeche D (2013) Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J Am Heart Assoc 2(2):e000078. doi: 10.1161/JAHA.113.000078
29. Kashiyama K, Mitsutake N, Matsuse M, Ogi T, Saenko VA, Ujifuku K, Utani A, Hirano A, Yamashita S (2012) miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts. J Invest Dermatol 132(6):1597-1604. doi: 10.1038/jid.2012.22
30. Kawashita Y, Jinnin M, Makino T, Kajihara I, Makino K, Honda N, Masuguchi S, Fukushima S, Inoue Y, Ihn H (2011) Circulating miR-29a levels in patients with scleroderma spectrum disorder. J Dermatol Sci 61(1):67-69. doi: 10.1016/j.jdermsci.2010.11.007
31. Kumarswamy R, Volkmann I, Thum T (2011) Regulation and function of miRNA-21 in health and disease. RNA Biol 8(5):706-713. doi: 10.4161/rna.8.5. 16154
32. Lamouille S, Subramanyam D, Blelloch R, Derynck R (2013) Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr Opin Cell Biol 25(2):200-207. doi: 10.1016/j.ceb.2013.01.008
33. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327(5962):198-201. doi: 10.1126/science.1178178
34. Li H, Yang R, Fan X, Gu T, Zhao Z, Chang D, Wang W (2012) MicroRNA array analysis of microRNAs related to systemic scleroderma. Rheumatol Int 32(2):307-313. doi: 10.1007/s00296-010-1615-y
35. Lindow M, Kauppinen S (2012) Discovering the first microRNA-targeted drug. J Cell Biol 199(3):407-412. doi: 10.1083/jcb.201208082
36. Liu Y, Yang D, Xiao Z, Zhang M (2012) miRNA expression profiles in keloid tissue and corresponding normal skin tissue. Aesthet Plast Surg 36(1):193-201. doi: 10.1007/s00266-011-9773-1
37. Liu Z, Lu CL, Cui LP, Hu YL, Yu Q, Jiang Y, Ma T, Jiao DK, Wang D, Jia CY (2012) MicroRNA-146a modulates TGF-beta1-induced phenotypic differentiation in human dermal fibroblasts by targeting SMAD4. Arch Dermatol Res 304(3):195-202. doi: 10.1007/s00403-011-1178-0
38. Makino K, Jinnin M, Hirano A, Yamane K, Eto M, Kusano T, Honda N, Kajihara I, Makino T, Sakai K, Masuguchi S, Fukushima S, Ihn H (2013) The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma. J Immunol 190(8):3905-3915. doi: 10.4049/jimmunol.1200822
39. Makino K, Jinnin M, Kajihara I, Honda N, Sakai K, Masuguchi S, Fukushima S, Inoue Y, Ihn H (2012) Circulating miR-142-3p levels in patients with systemic sclerosis. Clin Exp Dermatol 37(1):34-39. doi: 10.1111/j.1365-2230.2011.04158.x
40. Mattes J, Collison A, Plank M, Phipps S, Foster PS (2009) Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci USA 106(44):18704-18709. doi: 10.1073/pnas.0905063106
41. Maurer B, Stanczyk J, Jungel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH, Gay S, Distler O (2010) MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthr Rheum 62(6):1733-1743. doi: 10.1002/art.27443
42. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513-10518. doi: 10.1073/pnas. 0804549105
43. Molnar V, Tamasi V, Bakos B, Wiener Z, Falus A (2008) Changes in miRNA expression in solid tumors: an miRNA profiling in melanomas. Semin Cancer Biol 18(2):111-122. doi: 10.1016/j.semcancer.2008.01.001
44. Ning MS, Andl T (2013) Control by a hair's breadth: the role of microRNAs in the skin. Cell Mol Life Sci 70(7):1149-1169. doi: 10.1007/s00018-012-1117-z
45. Palmer TD, Rosman GJ, Osborne WR, Miller AD (1991) Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci USA 88(4):1330-1334
46. Parapuram SK, Shi-wen X, Elliott C, Welch ID, Jones H, Baron M, Denton CP, Abraham DJ, Leask A (2011) Loss of PTEN expression by dermal fibroblasts causes skin fibrosis. J Invest Dermatol 131(10):1996-2003. doi: 10.1038/jid.2011.156
47. Pastar I, Khan AA, Stojadinovic O, Lebrun EA, Medina MC, Brem H, Kirsner RS, Jimenez JJ, Leslie C, Tomic-Canic M (2012) Induction of specific microRNAs inhibits cutaneous wound healing. J Biol Chem 287(35):29324-29335. doi: 10.1074/jbc.M112.382135
48. Patel V, Noureddine L (2012) MicroRNAs and fibrosis. Curr Opin Nephrol Hypertens 21(4):410-416. doi: 10.1097/MNH.0b013e328354e559
49. Peng WJ, Tao JH, Mei B, Chen B, Li BZ, Yang GJ, Zhang Q, Yao H, Wang BX, He Q, Wang J (2012) MicroRNA-29: a potential therapeutic target for systemic sclerosis. Expert Opin Ther Targets 16(9):875-879. doi: 10.1517/14728222.2012. 708339
50. Postlethwaite AE, Shigemitsu H, Kanangat S (2004) Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr Opin Rheumatol 16(6):733-738
51. Qu L, Liu A, Zhou L, He C, Grossman PH, Moy RL, Mi QS, Ozog D (2012) Clinical and molecular effects on mature burn scars after treatment with a fractional CO(2) laser. Lasers Surg Med 44(7):517-524. doi: 10.1002/lsm.22055
52. Romano C, Schepis C (2012) PTEN gene: a model for genetic diseases in dermatology. Sci World J 2012:252457. doi: 10.1100/2012/252457
53. Sand M, Gambichler T, Sand D, Skrygan M, Altmeyer P, Bechara FG (2009) MicroRNAs and the skin: tiny players in the body's largest organ. J Dermatol Sci 53(3):169-175. doi: 10.1016/j.jdermsci.2008.10.004
54. Satoh M, Chan JY, Ceribelli A, Vazquez del-Mercado M, Chan EK (2013) Autoantibodies to Argonaute 2 (Su antigen). Adv Exp Med Biol 768:45-59. doi: 10.1007/978-1-4614-5107-5-4
55. Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H, Yan L, Malhotra A, Vatner D, Abdellatif M (2008) MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell 19(8):3272-3282. doi: 10.1091/mbc.E08-02-0159
56. Schlauder SM, Ahmad A, Horn TD (2009) Dicer and micro-RNAs in cutaneous disease. J Cutan Pathol 36(5):607-610. doi: 10.1111/j.1600-0560.2009.01311.x
57. Schneider MR (2012) MicroRNAs as novel players in skin development, homeostasis and disease. Br J Dermatol 166(1):22-28. doi: 10.1111/j.1365-2133. 2011.10568.x
58. Sing T, Jinnin M, Yamane K, Honda N, Makino K, Kajihara I, Makino T, Sakai K, Masuguchi S, Fukushima S, Ihn H (2012) microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma. Rheumatology 51(9):1550-1556. doi: 10.1093/rheumatology/kes120
59. Siprashvili Z, Khavari PA (2004) Lentivectors for regulated and reversible cutaneous gene delivery. Mol Ther J Am Soc Gene Ther 9(1):93-100
60. Sonkoly E, Stahle M, Pivarcsi A (2008) MicroRNAs: novel regulators in skin inflammation. Clin Exp Dermatol 33(3):312-315. doi: 10.1111/j.1365-2230. 2008.02804.x
61. Sonkoly E, Wei T, Janson PC, Saaf A, Lundeberg L, Tengvall-Linder M, Norstedt G, Alenius H, Homey B, Scheynius A, Stahle M, Pivarcsi A (2007) MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS ONE 2(7):e610. doi: 10.1371/journal.pone.0000610
62. Tan WQ, Gao ZJ, Xu JH, Yao HP (2011) Inhibiting scar formation in vitro and in vivo by adenovirus-mediated mutant Smad4: a preliminary report. Exp Dermatol 20(2):119-124. doi: 10.1111/j.1600-0625.2010.01186.x
63. Tang O, Chen XM, Shen S, Hahn M, Pollock CA (2013) miRNA-200b represses transforming growth factor-beta1-induced EMT and fibronectin expression in kidney proximal tubular cells. Am J Physiol Renal Physiol 304(10):F1266-F1273. doi: 10.1152/ajprenal.00302.2012
64. Thombs BD, Haines JM, Bresnick MG, Magyar-Russell G, Fauerbach JA, Spence RJ (2007) Depression in burn reconstruction patients: symptom prevalence and association with body image dissatisfaction and physical function. Gen Hosp Psychiatry 29(1):14-20. doi: 10.1016/j.genhosppsych.2006.09.002
65. Thombs BD, Notes LD, Lawrence JW, Magyar-Russell G, Bresnick MG, Fauerbach JA (2008) From survival to socialization: a longitudinal study of body image in survivors of severe burn injury. J Psychosom Res 64(2):205-212. doi: 10.1016/j.jpsychores.2007.09.003
66. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J, Engelhardt S (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456(7224):980-984. doi: 10.1038/nature07511
67. Tili E, Michaille JJ, Gandhi V, Plunkett W, Sampath D, Calin GA (2007) miRNAs and their potential for use against cancer and other diseases. Future Oncol 3(5):521-537. doi: 10.2217/14796694.3.5.521
68. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137(6):1032-1046. doi: 10.1016/j.cell.2009.03.047
69. Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L (2007) Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 67(7):2912-2915. doi: 10.1158/0008-5472.CAN-07-0520
70. Varga J (2011) Systemic sclerosis (scleroderma) and related disorders. In: Harrison's principles of internal medicine, 18th edn. McGraw-Hill, New York
71. Vettori S, Gay S, Distler O (2012) Role of MicroRNAs in Fibrosis. Open Rheumatol J 6:130-139. doi: 10.2174/1874312901206010130
72. Wang T, Feng Y, Sun H, Zhang L, Hao L, Shi C, Wang J, Li R, Ran X, Su Y, Zou Z (2012) miR-21 regulates skin wound healing by targeting multiple aspects of the healing process. Am J Pathol 181(6):1911-1920. doi: 10.1016/j.ajpath. 2012.08.022
73. Wang Y, Huang C, Reddy Chintagari N, Bhaskaran M, Weng T, Guo Y, Xiao X, Liu L (2013) miR-375 regulates rat alveolar epithelial cell trans- differentiation by inhibiting Wnt/beta-catenin pathway. Nucleic Acids Res 41(6):3833-3844. doi: 10.1093/nar/gks1460
74. Wei J, Bhattacharyya S, Tourtellotte WG, Varga J (2011) Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy. Autoimmun Rev 10(5):267-275. doi: 10.1016/j.autrev.2010.09.015
75. Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18(7):1028-1040. doi: 10.1038/nm.2807
76. Xiao J, Yang B, Lin H, Lu Y, Luo X, Wang Z (2007) Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4. J Cell Physiol 212(2):285-292. doi: 10.1002/jcp.21062
77. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A, O'Brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL, Coukos G (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103(24):9136-9141. doi: 10.1073/pnas.0508889103
78. Zhu H, Li Y, Qu S, Luo H, Zhou Y, Wang Y, Zhao H, You Y, Xiao X, Zuo X (2012) MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma. J Clin Immunol 32(3):514-522. doi: 10.1007/s10875-011-9647-y
79. Zhu H, Luo H, Li Y, Zhou Y, Jiang Y, Chai J, Xiao X, You Y, Zuo X (2013) MicroRNA-21 in scleroderma fibrosis and its function in TGF-beta-regulated fibrosis-related genes expression. J Clin Immunol 33(6):1100-1109. doi: 10.1007/s10875-013-9896-z
80. Beyer C, Dees C, Distler JH (2013) Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis. Arch Dermatol Res 305:1-8